Literature DB >> 2625774

Pigmentary retinal degeneration in patients with HTLV-I-associated myelopathy.

K Nakao1, N Ohba, M Isashiki, Y Isashiki, K Unoki, M Osame.   

Abstract

Ophthalmological evaluations were made of the records of a series of 38 patients with HTLV-I-associated myelopathy, a chronic progressive myelopathy caused by human T-lymphotropic virus type I (HTLV-I). Four patients with no contributory family history showed pigmentary degenerative changes of the retina and choroid. Two of the patients (73-year-old woman, 68-year-old woman) had a progressive visual loss and night blindness with morphologic and functional features of diffuse pigmentary retinal degeneration. The other two patients (59-year-old man, 72-year-old man) complained of recently developed visual loss with sectorial or regional retinochoroidal atrophy. These elderly patients claimed that they had been healthy until a few years before presentation, not only visually but also neurologically. It was concluded, together with an epidemiologic consideration, that the coexistence of pigmentary retinal degeneration and HTLV-I-associated myelopathy is not simply chance but indicates a close association between the two conditions. It is proposed that HTLV-I infection might be a primary causative factor of degenerative changes of the retina and choroid, although the pathogenesis remains to be defined.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2625774

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  5 in total

Review 1.  HTLV-I infection in human disease.

Authors:  D J Spalton; F Nicholson
Journal:  Br J Ophthalmol       Date:  1991-03       Impact factor: 4.638

2.  Clinical features of HTLV-I associated uveitis.

Authors:  K Nakao; N Ohba
Journal:  Br J Ophthalmol       Date:  1993-05       Impact factor: 4.638

Review 3.  Human T lymphotropic virus type 1 uveitis.

Authors:  M Mochizuki; K Tajima; T Watanabe; K Yamaguchi
Journal:  Br J Ophthalmol       Date:  1994-02       Impact factor: 4.638

4.  Seroprevalence of antibodies to HTLV-I in patients with ocular disorders.

Authors:  K Nakao; M Matsumoto; N Ohba
Journal:  Br J Ophthalmol       Date:  1991-02       Impact factor: 4.638

5.  Visualization of HTLV-1-specific cytotoxic T lymphocytes in the spinal cords of patients with HTLV-1-associated myelopathy/tropical spastic paraparesis.

Authors:  Eiji Matsuura; Ryuji Kubota; Yuetsu Tanaka; Hiroshi Takashima; Shuji Izumo
Journal:  J Neuropathol Exp Neurol       Date:  2015-01       Impact factor: 3.685

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.